hers glp 1 reddit Questions about & compound semaglutide : r/HersWeightloss Hims & Hers announces access

The top doctors at Blue Fin Vision explain that this occurs because sudden changes in glucose levels can destabilise the fragile blood vessels in the retina, potentially causing: Retinal haemorrhaging Macular oedema (fluid accumulation in the central vision area) Temporary vision fluctuations Blurred vision due to refractive changes Symptoms and Warning Signs Patients taking GLP-1 medications should remain vigilant for specific symptoms that warrant immediate attention from top specialists: Immediate Concern Symptoms: Sudden, painless vision loss in one or both eyes Rapidly worsening eyesight New onset of persistent blurred vision Floaters or flashing lights Central vision disturbances Early Warning Signs: Gradual vision changes over weeks Difficulty with night vision Fluctuating vision throughout the day New visual field defects The best eye care professionals at our London clinics emphasise that any sudden vision changes during GLP-1 treatment require urgent evaluation

Sleep and Stress Management : Focus on optimizing sleep quality and managing stress levels, as these factors significantly impact appetite regulation and weight management success

Key takeaways People with type 2 diabetes should always consult a doctor before discontinuing metformin, as abrupt cessation can lead to increased blood sugar levels

There's a lot to unpack, so we've structured our thoughts into three distinct sectionsfeel free to peruse the whole post or jump forward to specific areas of interest using the links below: We'll start by sharing our about where the innovation race is headingand what it means for the industry key insights and predictions From there, we'll overview (including key differentiators between major competitors Eli Lilly and Novo Nordisk) what the race has looked to date Finally, we'll go deep on the that will define the innovation race moving forward: five vectors of innovation GLP-1 innovation: Key insights and predictions GLP-1s are more than a blockbuster drug class, they signal a profound reordering of how chronic disease is managed, financed, and even understood

Beyond CagriSema, researchers are exploring GLP-1 combined with FGF21 analogues, GLP-1 combined with leptin sensitizers, and even triple or quadruple receptor agonists